Pleural mesothelioma is the most common form of mesothelioma by far and accounts for 75% of all mesothelioma cases. Pleural mesothelioma affects the respiratory areas of the body such as the lungs. More specifically, the cancer attacks the lining of the lungs and ribs called the pleura hence the name pleural mesothelioma.

The main cause of pleural mesothelioma is exposure to asbestos. Only a couple of months of being exposed to the deadly dust and fibres of asbestos without protection can lead to pleural mesothelioma thirty to fifty years later. Elderly men of ages sixty to seventy are those most at risk to asbestos because this was the generation which worked with asbestos with little protection from the dust and fibres. Due to the long latency period of pleural mesothelioma (30-50 years), these men are only just discovering they have the deadly cancer. Currently, many of these men are lodging million dollar lawsuits against the companies who exposed them to asbestos. Asbestos fibres get into the lining of the lungs by inhalation and become lodged inside the lungs.

The symptoms that are associated with pleural mesothelioma include persistent coughing, difficulty swallowing, facial swelling, weight loss, fever, rasping and coughing up blood. Patients may additionally experience shortness of breath because as the tumour on the lining of the lungs expands, this leaves less room for the lungs to function properly. Some patients also begin to feel severe pains in their chest and this is due to the spreading of cancerous cells. A lot of these symptoms are similar to diseases and conditions which are far more common than mesothelioma which means that pleural mesothelioma is often very difficult to diagnose until it is too late.

Treatment of pleural mesothelioma is limited and as yet there is no proper cure. Research is being conducted in labs all over the United States and many pharmaceutical companies are also testing for new treatments. Treatments for pleural mesothelioma include chemotherapy, radiation therapy and surgery. A patient’s age, medical record, weight and other such factors are taken into account before treatment. Generally, chance of survival is far more likely if pleural mesothelioma is treated aggressively in its early stages because once the cancer has developed and matured it is very difficult to cure.

All the detailed information you need on the symptoms, treatment, risks, science and more about mesothelioma can be found at:

http://www.1-mesothelioma.co.uk

Be sure to visit to learn more about this deadly cancer and how you can prevent it.

Tags: Cancer, Aging

Pleural mesothelioma patients treated with both cisplatin and raltitrexed may survive longer than patients who receive cisplatin alone, according to a recent study conducted in Europe and Canada (J Clin Oncol. 2005 Oct 1; 23(28): 6881-9). Raltitrexed (Tomudex) works by interfering with the ability of tumor cells to multiply and make deoxyribonucleic acid or DNA. Cisplatin is a traditional chemotherapy drug.

Two hundred fifty pleural mesothelioma patients took part in a clinical trial to determine the safety and effectiveness of raltitrexed. One hundred twenty-four patients took cisplatin and the rest took cisplatin plus raltitrexed. Most were men with an average age of 58 who had not received other chemotherapy treatments.

The raltitrexed study was a “phase III” clinical trial, as defined by the European Organization for Research and Treatment of Cancer. A phase III trial compares a new cancer treatment with a standard treatment, and requires a large number of participants. It follows a phase II clinical trial, which is concerned with the safety of a new treatment and how to administer it, and a basic phase I clinical trial, which tests the drug’s effectiveness on a small number of patients.

Survival Increased in Patients Treated with Raltitrexed
The researchers looked at survival, progression of pleural mesothelioma, safety, tumor response rates, and the patient’s quality of life. They found the following:

» Forty-six percent of pleural mesothelioma patients in the cisplatin/raltitrexed group survived at least one year, compared to 40% of those in the cisplatin group.

» The average survival was 11.4 months for patients in the cisplatin/raltitrexed group, but only 8.8 months for patients in the cisplatin group.

» Twenty-four percent of patients treated with cisplatin/raltitrexed had a positive response against pleural mesothelioma compared to 14% of patients treated with cisplatin.

» The overall quality of life was about the same in the cisplatin group as compared to the cisplatin/raltitrexed group.

A small number of patients in both the cisplatin and cisplatin/raltitrexed groups developed low white blood cell counts (neutropenia). Other side effects included fatigue, nausea, and vomiting, which were more common in the combined drug group.

Raltitrexed Is Related to the Pleural Mesothelioma Drug Alimta®
Raltitrexed is in the class of chemotherapy drugs called antifolates. It blocks the production of thymidylate synthase, which in turn decreases the mesothelioma cell’s ability to make DNA, the basic genetic material involved in cell reproduction. It is registered in Europe for the treatment of advanced colorectal cancer.

Raltitrexed is closely related to pemetrexed (Alimta®), another antifolate. Currently, pemetrexed/cisplatin is the only chemotherapy drug combination that the US Food and Drug Administration has approved to treat pleural mesothelioma.

The authors of the raltitrexed study concluded that combining cisplatin with an antifolate such as raltitrexed or pemetrexed is more helpful in treating pleural mesothelioma than using cisplatin alone. They also felt that cisplatin plus raltitrexed did not have a harmful effect on the patient’s quality of life.

More information: http://www.mesothelioma-info-asbestos.com/

Tags: Aging, Health

Malignant pleural mesothelioma is a cancer of the thin layer of tissue that lines the chest and lungs. It is a rare form of cancer that is mostly associated with exposure to asbestos. Malignant pleural mesothelioma is a fast-moving cancer with a median survival time of between one and two years.

The majority of mesotheliomas are associated with asbestos exposure. Asbestos was used widely in the United States for insulation, and while awareness of its harmful effects is increasing, asbestos can still be found in older buildings. People who work in industries using asbestos in some form, such as insulation manufacturers, insulation workers, and ship builders, may be at increased risk to develop mesotheliomas. The time between exposure and development of a cancer may be decades, which is why it is usually diagnosed in older people. More men than women get this type of cancer. Close contacts of people who have been exposed to asbestos, such as family members, may also be at risk.

Some symptoms of this cancer are increasing breathlessness, pain in the chest or under the ribcage, an abdominal lump or swelling, fever and unexplained weight loss. Imaging tests like a CT scan may show a collection of fluid in the pleural cavity of the chest. Pleural tissue and fluid is also tested to detect cancerous cells and certain chemicals that can rule out a diagnosis of pleural mesothelioma.

Depending on the extent of spread of cancer, malignant pleural mesotheliomas are conventionally treated with some combination of chemotherapy, radiotherapy and surgery to remove as much of the cancer as possible. Aggressive treatment strategies are the norm, though the exact treatment depends on how far the cancer has spread. A number of experimental treatments are currently being evaluated in clinical trials.

Malignant Mesothelioma provides detailed information about malignant mesothelioma, diffuse malignant pleural mesothelioma, malignant mesothelioma diagnosis, malignant mesothelioma lawyer and more. Malignant Mesothelioma is the sister site of Peritoneal Mesothelioma Lawyers.

Tags: Medical, Disease

Diffuse malignant pleural mesothelioma, or DMM, is a rare but highly aggressive type of cancer. It occurs in the thin layer of tissue, the pleura, lining the chest cavity and lungs. Once diagnosed with DMM, most patients do not survive beyond one year. This cancer is more common in men than in women, and in older people.

Most people with DMM have a history of exposure to asbestos; however, if they are not aware that such exposure occurred, they may be unaware that they are at risk. A patient with DMM typically has one or more of the following signs and symptoms: chest pain, shortness of breath, unexplained weight loss, fatigue, fever, or a cough. An x-ray usually shows that the pleural tissue around the lungs has thickened due to the development of a number of nodules or small cancerous growths. Sometimes, there may be a single large growth. When a biopsy of the cancer tissue is done, the types of cells that make up the cancer may be epithelioid, mixed, or sarcomatoid. People with epithelioid cell cancers tend to survive somewhat longer; those with sarcomatoid cancers usually have the shortest survival.

DMM is always treated as aggressively as possible. The type of treatment depends on the dominant cell type the cancer is made of, the extent of spread of the cancer, and the overall health of the person undergoing treatment. Surgery is a preferred option where the bulk of the cancer can be removed. Many anti-cancer drugs are being tried to treat DMM, with varying levels of short-term success. Radiotherapy may also be an option. A number of clinical trials are currently underway to try and find a treatment that may improve the outlook for DMM patients. However, only seven percent of people with DMM survive beyond five years.

Malignant Mesothelioma provides detailed information about malignant mesothelioma, diffuse malignant pleural mesothelioma, malignant mesothelioma diagnosis, malignant mesothelioma lawyer and more. Malignant Mesothelioma is the sister site of Peritoneal Mesothelioma Lawyers.

Tags: Health, Cancer

Malignant pleural mesothelioma is the most common type of malignant mesothelioma. Many factors may be involved in determining the survival rate for this aggressive cancer; some are better understood than others. Estimates of median survival time range from one to two years; survival depends on underlying factors such as the type and extent of spread of the mesothelioma. Only seven percent of people with this cancer survive to five years after diagnosis, but this outlook is gradually improving with some promising experimental treatments. Some people live well beyond five years from the time of diagnosis.

In general, younger age at diagnosis, absence of weight loss and limited loss of lung function are associated with chances for increased survival. Stage I mesotheliomas, which have not spread to the lymph nodes or adjacent tissues and organs, also carry the best prognosis. The type of cell the cancer is comprised of can also affect survival. The epithelioid cell type has the best prognosis, the mixed or biphasic cell type the next best prognosis, and the sarcomatoid cell type the worst prognosis. The majority of malignant pleural mesotheliomas are of the epithelioid cell type.

Because this cancer takes so long to manifest, people are usually diagnosed at an older age and with more advanced disease, potentially worsening the prognosis and the treatment options available. The more aggressive the treatment, the better the outcome may be, but in cases with cancer that has spread to other parts of the body, chemotherapy may be the only alternative. New drugs, such as the combination of Alimta with Platinol, have been shown to improve survival in malignant mesothelioma patients whose only option is chemotherapy. A number of experimental treatments, such as immunotherapy and biotherapy, are currently being evaluated in clinical trials.

Malignant Mesothelioma provides detailed information about malignant mesothelioma, diffuse malignant pleural mesothelioma, malignant mesothelioma diagnosis, malignant mesothelioma lawyer and more. Malignant Mesothelioma is the sister site of Peritoneal Mesothelioma Lawyers.

Tags: Aging, Medical

Nearly 75 percent of mesotheliomas are initiated in the chest and are called pleural mesotheliomas. Pleural mesothelioma is the most common form of this devastating disease. This occurs when asbestos fibers enter the pleura, which is the membrane that covers the lungs, and results in the formation of malignant cells. The people most at risk of developing this rare form of cancer are construction workers who have been exposed to asbestos fibers for extended periods of time, their families, who are exposed to the asbestos fibers that collect on the clothes of the workers, and people who live or work in buildings that are insulated with asbestos material.

The risk of developing malignant pleural mesothelioma depends on several factors, such as the length of time the person has been exposed, and the nature of the asbestos fibers involved as well as the different kinds of industries. Other factors can also contribute to onset of pleural mesothelioma.

The symptoms at the initial stage can resemble that of pneumonia. When malignant mesothelioma originates in the pleural cavity, the first symptom may be a mild pain in the chest or back. When malignant pleural mesothelioma spreads, organs and tissues in the immediate area can be affected. It grows into the chest wall, muscles and ribs. The pain changes from mild, general and episodic to severe, localized and chronic as the disease progresses. Severe pain may not respond to oral doses, intravenous infusions, or intramuscular injections of analgesics or narcotics.

There are at least two other forms of mesothelioma, but pleural mesothelioma responds best to treatment. Unfortunately, the fatality rate remains high. However, extensive research is going on to alleviate the pain of mesothelioma sufferers, develop a vaccine, and treat the progression of the cancer.

Mesothelioma provides detailed information about malignant mesothelioma, asbestos and mesothelioma, mesothelioma, mesothelioma research and more. Mesothelioma is the sister site of Asbestos Exposure.

Tags: Illness, Disease

The earlier symptoms of malignant pleural mesothelioma are very similar to those experienced with other lung conditions, such as pneumonia or lung cancer. Symptoms also tend to present very gradually, and may therefore go unnoticed for a while. Breathlessness is one of the early and more common symptoms of pleural mesothelioma. This may present as a recent onset of shortness of breath, or a recent increase in shortness of breath. Breathlessness may be caused by a buildup of fluid (pleural effusion) in the space surrounding the lungs. This buildup of fluid may be removed periodically to make breathing easier. Certain substances may also be introduced into the space between the pleural membranes where fluid collects. These substances cause an inflammatory reaction in the pleural membranes, causing them to fuse together and thereby preventing the formation and collection of more fluid.

The thickening of the pleural membranes due to the growth of cancer cells also restricts lung function and contributes to breathlessness. Sometimes, this thickened tissue may require surgical removal to restore some lung function. The removal process is called decortication or pleurectomy.

Malignant mesotheliomas tend to spread fairly rapidly to other parts of the body, and this spread can result in additional symptoms. When pleural mesothelioma spreads to the chest wall and other tissues in the chest, it can result in severe pain. Even before the cancer spreads, chest pain, particularly in the lower chest and side, may be experienced. Chest pain tends to become progressively worse as the cancer spreads. Severe pain may be treated with strong pain-relieving drugs or with radiotherapy. When pleural mesothelioma spreads to the lungs, symptoms that are typically seen in lung cancer, such as hoarseness and coughing up of blood, may be present.

As with other cancers, the effect of pleural mesothelioma is widespread. The increased metabolism caused by cancer cells results in fever, weight loss and fatigue.

Mesothelioma Symptoms provides detailed information on Advanced Mesothelioma Symptoms, Clinical Mesothelioma Symptoms, Mesothelioma Diagnosis: An Introduction, Mesothelioma Stomach Symptoms and more. Mesothelioma Symptoms is affiliated with Pleural Mesothelioma Information.

Tags: Aging, Medical

Mesothelioma Pleural or Pleural Mesothelioma is generally a severe form of cancer that affects the membrane lining in the thoracic cavity. There are a few benign cases as well. The inhaling of asbestos dust either during the mining or manufacturing or handling of the material or from the systems and applications in which it is used is believed to be cause of this sickness.

The latency period, that is, the time taken for the symptoms to manifest, is anywhere from twenty to forty years. The time lag may even extend to fifty years. Because of this, most patients diagnosed with this disease are in the age group of sixties or seventies. Some may not even remember their exposure to asbestos. By the time the warning signs are noticed and correctly diagnosed, the disease may be in an advanced stage where treatment could be non-effectual.

Unfortunately, mesothelioma pleural doesn’t have any distinctive symptoms that prima facie identify the disease. The usual indications are dyspnea (shortness of breath), persistent coughing, disphagia (difficulty in swallowing), and tightness in chest accompanied by chest pain. Some patients may develop swelling of the neck, face and arms. This may indicate that the mesothelioma has spread. There could also be wheezing, hoarseness, fever and sweating, fatigue, sensory loss and nausea. At the advanced stage there may be hymoptysis (coughing up of blood).

The symptoms are mainly caused by effusion, which in this case means fluid collection in the thoracic area. Also, the delicate membrane covering the lungs may thicken and thus reduce expansion and contraction. In certain cases no perceptible signs may show till the cancer has spread beyond control.

Out of the symptoms of mesothelioma pleural the major ones are shortness of breath (90%) and weight loss (29%). About 84% of patients have pleural effusions (fluid collection).

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Tags: Disease, Illness

Mesothelioma Pleural is a lethal cancer that initially affects the thin membrane enveloping the lungs. This affliction is mostly caused by exposure to asbestos. Currently about 3000 cases are reported in the United States every year. But according to reliable estimates, nearly 8 million people have been exposed to asbestos during the past fifty years and about .3 million new cases would turn up by 2030. Higher rate of incidence is noted in the Pacific and Mid-Atlantic States.

The disease is almost always fatal. If it is detected early, surgery could be helpful. But the problem is that Mesothelioma Pleural has a long latent period of 20 to 40 years or more and by the time it is diagnosed the cancer would be usually in an advanced stage. There is no universally accepted line of treatment as of now. Chemotherapy is not considered effective. Several combination therapies are tried.

Radiation may be of use, particularly as a palliative measure. Here the problem is that since mesothelioma is resistant to radiation, high doses have to be applied. This, not only kill the cancerous cells but also the good ones. To overcome the difficulty, many doctors who treat mesothelioma pleural patients are employing a century old procedure known as Brachytherapy, which was being, and still is, used for treatment of certain other cancers.

Brachytherapy today is a high-tech and precise form of radiation. It is a process applied internally instead of through a gadget outside the body. Radioactive sources (sealed in needles, catheters, seeds or wires) are planted on the tumor or very close to it. By this process the radiation is focused on the bad cells and therefore spares the good ones. This has been found to be effective.

Like all radiation, Brachytherapy also has side effects. But they are minor ones like short duration soreness in the area where the procedure is done. There is nothing to worry about if the patient follows the doctor’s instructions.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Tags: Cancer, Medical

2006

Malignant Pleural Mesothelioma is a lethal cancer that starts in the lining of the lungs. The main cause is believed to be unprotected contact with asbestos. Every year about 3000 new cases of this disease are reported in the United States. It is estimated that over the past fifty years nearly eight million people have been exposed to asbestos and that 300,000 new cases would be reported by the year 2030. The peak may be around 2020 and thereafter the incidence is likely to taper down because of the preventive measures that are being taken.

Like in all cases of cancer, early detection and appropriate treatment improve the survival rate. On both counts the pleural mesothelioma patients are at a disadvantage. Symptoms take anywhere between 20 to 50 years to manifest. Because of this, the patients are generally in the fifty plus age group. And the outwardly noticed indications of the sickness are similar to that of several lesser ailments. This makes the diagnosis difficult. Because of all these, by the time the problem is detected, the cancer is likely to have spread. As yet there is no fully effective line of treatment. It is generally accepted that a combination therapy is better than monotherapy. A great deal of research is being done in this area.

A number of studies have been made about the survival rate among pleural mesothelioma patients. They all come to the same conclusion – the disease is almost always fatal. The lifespan of a person diagnosed with pleural mesothelioma is about six months to two years. There have been exceptions and their stories are inspiring. The life expectancy varies according to the stage (pleural mesothelioma has four different phases) and the type. One research based on the histologic (tissue structure)tests shows a median survival of 11 months – 9.4 months for sarcomatous, 12.5 months for epithelial and 11 months for mixed.

Several inspirational books are available for the patient to read and fortify himself. Also helpful are chat rooms with others in the same condition.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Tags: Health, Aging

Majority of mesothelioma (cancerous tumor affecting mesothelial cells of organs) cases come under the classification ‘pleural mesothelioma’. This is a cancer that originates in the pleura, the delicate membrane covering the lungs. Out of these, seventy five percent are diffuse malignant pleural mesethelioma. The balance is localized or benign.

Diffuse malignant pleural mesothelioma is, in most cases, caused by unprotected exposure to asbestos. The symptoms include shortness of breath and/or chest pain, loss of weight, cough, fatigue, swelling on the face, neck and arms, reduced appetite, and coughing up blood. There would be collection of fluid in the thoracic cavity. It may take from twenty to forty years or more after contact with asbestos for the symptoms to emerge. Because of the time lag, diagnosing is often difficult. Moreover, many doctors are not familiar with the disease.

Diagnostic procedure consists mostly of imaging with Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI) and Position Emission Tomography (PET), and laboratory tests and analysis. Thoractomy, which means making an incision through the chest wall to look into the pleura (the membrane lining the lungs and the thoracic cavity) and pleural biopsy provide conclusive evidence.

Diffuse malignant pleural mesothelioma tumor is very aggressive and spreads fast. There are several methods to gauge the stage of the cancer. The most common is known as TNM. T is for the size of the tumor, N for the number of lymph nodules involved, and M for metastasis (spread of the cancer). There are basically four different stages. Correct grading helps the doctors to decide on the course of treatment. If the affliction is detected at an early stage, the chances of longer survival are better.

But generally the prognosis (response to treatment) is not good in diffuse malignant pleural mesothelioma cases. Surgery during Stage I may help. If detected during the later phases of the cancer the survival rate is four months to twelve months. Radiotherapy and chemotherapy do not seem to improve the survival rate. The reality is that currently there is no effective curative treatment. Research is on to find new management methods and more effectual medicines.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Let us take the scenario of a seventy-year-old man, who is a nonsmoker and otherwise fairly healthy, approaching the local doctor with complaints of persistent cough, chest congestion and weight loss. Other symptoms may include difficulty in swallowing and loss of appetite. The physician has several options of diagnosis, but pleural mesothelioma, a lethal cancer that originates in the lining enveloping the lungs, may not be considered.

There are several reasons for this. Recognition of pleural mesothelioma as a separate disease entity started as recently as the 1960s. Currently only about 3000 cases are reported annually in the United States. Many doctors may not have seen a single such case during their career. The symptoms are similar to many lesser afflictions. The only general lead is that the disease seems to be more prevalent in the Pacific and Mid-Atlantic States. It is also known that the major cause for pleural mesothelioma is exposure to asbestos. But how much contact with the material leads to this disease is unclear. Even the family members of an asbestos worker are at risk from the dust he carries home on his body and clothing.

This form of cancer has a long latent period and the symptoms manifest only twenty to forty or more years after exposure to asbestos. This also vitiates the possibility of correct diagnosis.

Once the doctor eliminates the chances of other diseases and pursues the pleural mesothelioma line, the patient is subjected to a battery of tests and imaging procedures like x-ray and CT scan. Fluid collection in the thoracic cavity is an indicator, but not conclusive. Confirmation can be obtained with a pleural (pleura is the membrane covering the lungs) biopsy using an electron microscope.

Since pleural mesothelioma is an aggressive cancer, early detection and immediate introduction of appropriate management are of critical importance. The possibility of a doctor who fails to diagnose pleural mesothelioma or misdiagnoses it, being sued for medical malpractice cannot be totally ruled out. But usually the law applicable is asbestos product liability.

It is generally accepted that pleural mesothelioma is a disease that is difficult to diagnose. To help the doctor, the patient should inform him at the very outset about exposure to asbestos, if any.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Proper diagnosis of Pleural Mesothelioma, a form of cancer in the thoracic cavity caused by contact with asbestos, is of great importance because it enables the patient to get disease-specific treatment immediately and also arms him adequately for any lawsuit for compensation.

Unfortunately, diagnosis of this sickness is a very difficult process. The reasons are several. There are no specific to the disease outward signs. The symptoms like breathing difficulty, coughing, weight loss, chest and back pains, and fatigue among others are common to many ailments. They can confuse a doctor. And these indications take twenty to forty or fifty years after contact with asbestos to manifest. If some cases there may be no perceptible clues till the cancer has spread. Many doctors are unfamiliar with the disease. One key factor that would give the correct lead to a doctor is the information whether the patient had exposure to asbestos in the past. Since most of the pleural mesothelioma patients are in the sixty-seventy age group, there is the possibility that some of them may not recall details dating back forty or fifty years.

Diagnostic procedure starts with studying the patient’s medical history in detail and giving him a complete physical check up. Next comes imaging. This includes x-ray, CT (Computed Tomography) scan, MRI (magnetic resonance imaging) and PET (position emission tomography). These may reveal irregular thickening of the pleura (membrane lining the thorax), fluid collection in that area, congestion of the lungs, and mineral deposits. Magnified view and laboratory tests assist in determining whether chemicals found are the same as those seen in pleural mesothelioma cases. Analysis of fluid, tissues and lymph nodes helps in reaching a conclusion. Sometimes bronchoscopy, in which a lighted flexible tube is inserted through the moth, is done. Thorascopy in which the doctor looks into the chest cavity may also be performed. Finally, a pleural biopsy confirms the diagnosis.

An October 2005 report states that a new method that assists diagnosis of pleural mesothelioma is to measure the presence of osteopontin in blood.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Pleural mesothelioma is the most common existing form of this malignancy, and it is more often than not a direct consequence of exposure to asbestos. One can get minor tumors with mesothelioma, but the malignant form is the most widespread. Inhaling asbestos fibers puts you at risk, and working with the mineral without adequate protection is hazardous. These risks are further heightened with more exposure to the mineral, or smoking.

Pleural mesothelioma targets the respiratory areas of the body. The malignancy attacks the lining of the ribs and the lungs. Similar to other forms of the disease, the symptoms can be dormant for fifty years before presenting themselves.

Pleural mesothelioma can be a very tricky disease to detect. Often, symptoms are mistaken for common ailments. The lengthy latency period does not help matters, either.

If your physician has no knowledge of you working with asbestos, he may treat you for different ailments, the most common being pneumonia. However, if your doctor knows about you having previously worked with asbestos, he can start the appropriate treatment upon manifestation of the symptoms.

Pleural mesothelioma symptoms include difficulty in swallowing; persistent coughing; weight loss; facial swelling; coughing blood, etc. Some patients experience shortness of breath, even while resting. The spreading of the tumor can thicken the pleura, leading to such consequences.

Some patients experience extreme pain in the ribs or chest, also caused by the spread of the tumor. Should the tumor branch upwards, the lungs and the chest will also get affected.

Treating pleural mesothelioma depends on several things. The patient’s age, medical history, weight and general well-being are factors. Other factors include the location of the cancer and the extent to which the cancer has spread. Common treatments for pleural mesothelioma include surgery, chemotherapy and radiation therapy.

Mesothelioma Information provides detailed information on Mesothelioma Information, Mesothelioma Legal Information, Pleural Mesothelioma Information, Peritoneal Mesothelioma Information and more. Mesothelioma Information is affiliated with Clinical Mesothelioma Symptoms.

Pleural Mesothelioma is a serious ailment that affects the thoracic cavity. It is believed to be caused by inhaling asbestos dust. Most of the three thousand such cases reported in the United States every year are malignant. There are two important reasons for this. The disease has a long latency period of twenty to forty years. By the time the symptoms manifest, the cancer would have already set in. Secondly, the outward signs that emerge are similar to that of many common and less serious diseases, rendering diagnosis difficult. Usually the problem is identified too late.

The outward symptoms of pleural mesothelioma include breathing and swallowing difficulty, loss of weight, constant coughing, chest congestion and pain, spitting blood, and fever. Detailed investigations reveal irregular thickening of pleura and fluid collection, reduced space between the lung lobes, and mineral deposits.

Malignant pleural mesothelioma goes through four separate stages. Initially it is restricted to the pleura, the membrane in the thoracic cavity. Next the lymph nodes are affected. In the third stage there would be local spreading of the disease. Finally the cancer penetrates to other parts of the body. Often, death strikes within six to eighteen months of diagnosing the disease depending on the stage at which the problem was identified.

In the initial phase surgery may prove helpful to some extent. Other lines of treatment include Brachotherapy. Several doctors prefer a multi-modality approach aimed at prolonging survival and reducing pain. Exciting new developments like photodynamic therapy, immuno therapy and gene therapy are undergoing human clinical trials.

The sad part is that we are yet to see the full spectrum of the menace. The present strike rate of 3000 new pleural mesothelioma cases per year is only a starter. National Cancer Institute estimates that eight million people have been exposed to asbestos during the past fifty years and that 300,000 new cases of pleural mesothelioma could come up by 2030! It is essential that efforts be made on a war footing to develop new effective methods of prevention and treatment.

But pragmatically, for the present, a person diagnosed with malignant pleural mesothelioma and/or his close relatives should look for the best palliative care and a competent lawyer to sue for damages.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

Pleural Mesothelioma is a deadly form of cancer that affects the delicate membrane lining in the thorax. Sometimes a few benign cases are also noticed. Three thousand new incidences of pleural mesothelioma are reported in the United States every year. Usually the patient dies within eighteen months from diagnosis.

Unprotected contact with asbestos is the only known cause of this disease. The general view seems to be that most of the cases could have been possibly prevented if the asbestos manufacturers who knew about the ill effects of the product had warned their workers and taken the required safeguards. Today the industry is strapped with lawsuits totaling billions of dollars over the issue and some of the companies have gone bankrupt.

Pleural Mesothelioma is normally detected in people of the 60-70 years age group. This is mainly because the killer takes two to four decades to develop and manifest. Not only those who have worked in asbestos factories or have otherwise come into regular contact with material (like loading and unloading workers) but their families as well run the risk of being struck by the disease because of the asbestos dust the workers carry home on their bodies and clothing. Sometimes the heating systems are padded with asbestos to increase the efficiency. Till a few years back some ships used to be insulated with this toxic material.

The mesothelioma pleural patient goes through four distinctive stages en route to the inevitable end. Diagnosis is difficult for two reasons. First is the time lag for the symptoms to appear. Secondly the symptoms like shortness of breath, difficulty in swallowing, and weight loss, are common to several other diseases.

Traditional treatment for pleural mesothelioma is not very effective. If the problem is detected during the initial stage, surgery could possibly control it. In certain cases Brachytherapy could be a substitute for surgery. Pain management could be helped to some extent by radiotherapy. Chemotherapy doesn’t seem to be effectual. A great deal of research is afoot to discover better management procedures for pleural mesothelioma. Some new methods of treatment are being tried out.

Pleural Mesothelioma provides detailed information on Malignant Diffuse Pleural Mesothelioma, Malignant Pleural Mesothelioma, Malignant Pleural Mesothelioma Survival Rate, Mesothelioma Pleural Brachytherapy and more. Pleural Mesothelioma is affiliated with Peritoneal Mesothelioma Lawyers.

What is Pleural Mesothelioma?

Pleural Mesothelioma or malignant pleural mesothelioma is cancer in the layer of the lungs that can spread to the lungs. The spread of the tumor over the pleura results in pleural thickening. This hinders the reflexivity of the pleura and encases the lungs in an increasing restrictive belt. With the lungs thus restricted, they get constricted in no time and a person is always out of breath.

Pleural mesothelioma can be:

- Diffuse and malignant (carcinogenic)

- Localized and benign (non-cancerous)

Benign pleural mesothelioma can be removed surgically, but the malignant tumors are the real terror heads.

Most common among other mesothelioma cases, Pleural Mesothelioma is caused due to exposure to blue asbestos for a longer period of time, say 20 years, in which time the disease incubates only to show its fearful countenance via certain symptoms.

The symptoms of Pleural Mesothelioma

The symptoms of Pleural Mesothelioma include difficulty in breathing, difficulty in sleeping, pain in the chest and abdominal regions, blood vomits, weakness, weight loss, loss of appetite, lower back pains, persistent coughing, hoarseness of voice, sensory loss and difficulty in swallowing.

Diagnosis of Pleural Mesothelioma

The first step is to go through a chest X-ray or a CT scan (computed chest tomograph), which will reveal a pleural thickening and an effusion. This is followed by a bronchoscopy. However, it should always be left to a medical practitioner for a better understanding of the respective cases. Another method is a biopsy, which can be a needle biopsy, an open biopsy, or a thoracoscopy, where a mini camera is inserted inside the body and with that a tissue sample is attained for further diagnosis.

Treatment of Pleural Mesothelioma

Treatment is directly proportional to the time of the revelation of the disease, i.e., at an early stage the tumor can be removed through surgery.

A pioneering mesothelioma treatment option is immunotherapy, e.g., intrapleural inoculation of Bacillus Calmette-Guerin (BCG) is a useful mesothelioma treatment in which an effort is made to intensify the immune response.

Radiation treatment and chemotherapy is probably then the answer to the malignant pleural mesothelioma, but this can aid the pain management only; there’s no escaping death with Pleural Mesothelioma.

Side effects of Treatment

The side effects and penalty of mesothelioma lung cancer treatment are more than its treatment, which is damaged healthy tissues, a state of absolute fatigue ness; excessive radiation causes the skin to become red, dry and itchy.

Other side effects of radiotherapy are nausea and vomiting, diarrhea, urinary discomfort and a sudden reduction in the number of white blood corpuscles.

The average life span of a person with Pleural Mesothelioma is up to 6 months to a year and the maximum can reach up to 5 years – the magnesium-silicate mineral fibers take its toll that’s more than painful.

Other factors that may accelerate the possibility of pleural mesothelioma are chronic lung infections, tuberculous pleuritis, radiation (Thorotrast), exposure to the simian virus 40 (SV40) or mineral fibers (Zeolite) and tobacco smoking to a certain extent.

Pleural Mesothelioma does not give a person the avenue for fair play. Though the existence depends much on the various stages of the disease, it is an ultimate killing menace that sucks out the life of the common man.

Fred Lindell is a successful writer and publisher of
health related issues, for more informative articles go to
http://www.mesotheliomaplaza.com